149 related articles for article (PubMed ID: 32041737)
1. A Noncanonical Role of Fructose-1, 6-Bisphosphatase 1 Is Essential for Inhibition of Notch1 in Breast Cancer.
Lu C; Ren C; Yang T; Sun Y; Qiao P; Wang D; Lv S; Yu Z
Mol Cancer Res; 2020 May; 18(5):787-796. PubMed ID: 32041737
[TBL] [Abstract][Full Text] [Related]
2. Fructose-1, 6-bisphosphatase 1 interacts with NF-κB p65 to regulate breast tumorigenesis via PIM2 induced phosphorylation.
Lu C; Ren C; Yang T; Sun Y; Qiao P; Han X; Yu Z
Theranostics; 2020; 10(19):8606-8618. PubMed ID: 32754266
[No Abstract] [Full Text] [Related]
3. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
4. Fructose-1,6-bisphosphatase is a novel regulator of Wnt/β-Catenin pathway in breast cancer.
Li K; Ying M; Feng D; Du J; Chen S; Dan B; Wang C; Wang Y
Biomed Pharmacother; 2016 Dec; 84():1144-1149. PubMed ID: 27780144
[TBL] [Abstract][Full Text] [Related]
5. Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway.
Zhao W; Yang S; Chen J; Zhao J; Dong J
Life Sci; 2018 Oct; 210():224-234. PubMed ID: 30193944
[TBL] [Abstract][Full Text] [Related]
6. E3 ubiquitin ligase UBR5 promotes pancreatic cancer growth and aerobic glycolysis by downregulating FBP1 via destabilization of C/EBPα.
Chen L; Yuan R; Wen C; Liu T; Feng Q; Deng X; Du Y; Peng X
Oncogene; 2021 Jan; 40(2):262-276. PubMed ID: 33122826
[TBL] [Abstract][Full Text] [Related]
7. Fructose-1,6-bisphosphatase aggravates oxidative stress-induced apoptosis in asthma by suppressing the Nrf2 pathway.
Hu J; Wang J; Li C; Shang Y
J Cell Mol Med; 2021 Jun; 25(11):5001-5014. PubMed ID: 33960626
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting histone deacetylases suppresses glucose metabolism and hepatocellular carcinoma growth by restoring FBP1 expression.
Yang J; Jin X; Yan Y; Shao Y; Pan Y; Roberts LR; Zhang J; Huang H; Jiang J
Sci Rep; 2017 Mar; 7():43864. PubMed ID: 28262837
[TBL] [Abstract][Full Text] [Related]
9. HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer.
Fu D; Li J; Wei J; Zhang Z; Luo Y; Tan H; Ren C
Cell Commun Signal; 2018 Feb; 16(1):8. PubMed ID: 29463261
[TBL] [Abstract][Full Text] [Related]
10. Invalidation of mitophagy by FBP1-mediated repression promotes apoptosis in breast cancer.
Liu Y; Jiang Y; Wang N; Jin Q; Ji F; Zhong C; Zhang Z; Yang J; Ye X; Chen T
Tumour Biol; 2017 Jun; 39(6):1010428317708779. PubMed ID: 28653874
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the epithelial to mesenchymal transition and metastasis by Raf kinase inhibitory protein-dependent Notch1 activity.
Noh HS; Hah YS; Ha JH; Kang MY; Zada S; Rha SY; Kang SS; Kim HJ; Park JY; Byun JH; Hahm JR; Shin JK; Jeong SH; Lee YJ; Kim DR
Oncotarget; 2016 Jan; 7(4):4632-46. PubMed ID: 26716415
[TBL] [Abstract][Full Text] [Related]
12. A novel variant in the FBP1 gene causes fructose-1,6-bisphosphatase deficiency through increased ubiquitination.
Liang X; Liu X; Li W; Zhang L; Zhang B; Lai G; Zhao Y
Arch Biochem Biophys; 2023 Jul; 742():109619. PubMed ID: 37142076
[TBL] [Abstract][Full Text] [Related]
13. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation.
Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z
Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319
[TBL] [Abstract][Full Text] [Related]
14. Restoration of FBP1 suppressed Snail-induced epithelial to mesenchymal transition in hepatocellular carcinoma.
Liu GM; Li Q; Zhang PF; Shen SL; Xie WX; Chen B; Wu J; Hu WJ; Huang XY; Peng BG
Cell Death Dis; 2018 Nov; 9(11):1132. PubMed ID: 30429463
[TBL] [Abstract][Full Text] [Related]
15. Elevated expression of GNAS promotes breast cancer cell proliferation and migration via the PI3K/AKT/Snail1/E-cadherin axis.
Jin X; Zhu L; Cui Z; Tang J; Xie M; Ren G
Clin Transl Oncol; 2019 Sep; 21(9):1207-1219. PubMed ID: 30767161
[TBL] [Abstract][Full Text] [Related]
16. FBP1 regulates proliferation, metastasis, and chemoresistance by participating in C-MYC/STAT3 signaling axis in ovarian cancer.
Li H; Qi Z; Niu Y; Yang Y; Li M; Pang Y; Liu M; Cheng X; Xu M; Wang Z
Oncogene; 2021 Oct; 40(40):5938-5949. PubMed ID: 34363022
[TBL] [Abstract][Full Text] [Related]
17. FBP1-Altered Carbohydrate Metabolism Reduces Leukemic Viability through Activating P53 and Modulating the Mitochondrial Quality Control System In Vitro.
Xu Y; Tran L; Tang J; Nguyen V; Sewell E; Xiao J; Hino C; Wasnik S; Francis-Boyle OL; Zhang KK; Xie L; Zhong JF; Baylink DJ; Chen CS; Reeves ME; Cao H
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232688
[TBL] [Abstract][Full Text] [Related]
18. Decreased FBP1 expression rewires metabolic processes affecting aggressiveness of glioblastoma.
Son B; Lee S; Kim H; Kang H; Jeon J; Jo S; Seong KM; Lee SJ; Youn H; Youn B
Oncogene; 2020 Jan; 39(1):36-49. PubMed ID: 31444412
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway.
Bai L; Wang A; Zhang Y; Xu X; Zhang X
Exp Cell Res; 2018 May; 366(2):161-171. PubMed ID: 29548748
[TBL] [Abstract][Full Text] [Related]
20. ShRNA targeting Notch1 sensitizes breast cancer stem cell to paclitaxel.
Mao J; Song B; Shi Y; Wang B; Fan S; Yu X; Tang J; Li L
Int J Biochem Cell Biol; 2013 Jun; 45(6):1064-73. PubMed ID: 23500524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
